These findings support the importance of reliable ADH diagnosis procedures, as the utilization of chemoprophylaxis selective estrogen reuptake modulators (SERMs) to treat breast cancer may be an effective tool in reducing mortality [18]. This evidence concerns the gene AVP and breast cancer.